Literature DB >> 132332

Plasma growth hormone concentrations in Huntington's chorea.

O T Phillipson, E D Bird.   

Abstract

1. Growth hormone secretion was assessed in nine control subjects and nine patients with Huntington's chorea. 2. Early-morning fasting plasma samples from patients with Huntington's chorea contained abnormally high concentrations of growth hormone. 3. The suppression of growth hormone after oral glucose in choreic patients, unlike the control subjects, occurred at irregular intervals after the glucose was given and was followed, again at irregular intervals, by an exaggerated rebound phase. 4. The response to intravenous insulin was not markedly abnormal in choreic patients. However, there was a significant increase in the rate of rise of growth hormone concentration in the first half and hour after the insulin injection when compared with control subjects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132332     DOI: 10.1042/cs0500551

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  8 in total

1.  Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

Authors:  R J Chalmers; R H Johnson; H J Keogh; R N Nanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

2.  Insulin-induced hypoglycaemia does not abolish chorea.

Authors:  N P Quinn; A E Lang; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

3.  Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.

Authors:  Mahmoud A Pouladi; Yuanyun Xie; Niels Henning Skotte; Dagmar E Ehrnhoefer; Rona K Graham; Jeong Eun Kim; Nagat Bissada; X William Yang; Paolo Paganetti; Robert M Friedlander; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2010-01-22       Impact factor: 6.150

4.  Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.

Authors:  R Durso; C A Tamminga; S Ruggeri; A Denaro; S Kuo; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

5.  Studies of hypothalamic function in Huntington's chorea.

Authors:  P J Lavin; I Bone; P Sheridan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

6.  A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Authors:  Eirini Kalliolia; Edina Silajdžić; Rajasree Nambron; Seán J Costelloe; Nicholas G Martin; Nathan R Hill; Chris Frost; Hilary C Watt; Peter Hindmarsh; Maria Björkqvist; Thomas T Warner
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

7.  Neuroendocrine disturbances in Huntington's disease.

Authors:  Nadine Saleh; Stéphane Moutereau; Alexandra Durr; Pierre Krystkowiak; Jean-Philippe Azulay; Christine Tranchant; Emmanuel Broussolle; Françoise Morin; Anne-Catherine Bachoud-Lévi; Patrick Maison
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

Review 8.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.